ReviewInternational journal of pharmaceutics: X2026
Targeted Nanoparticle Delivery CRISPR/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision.
Sriwidodo Sriwidodo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.